Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 3/2019

01-09-2019 | Premature Rupture of Membranes | Maternal-Fetal Medicine

Insulin-like growth factor binding protein-1 predicts preterm premature rupture of membranes in twin pregnancies

Authors: Giovanni Sisti, Sara Paccosi, Astrid Parenti, Viola Seravalli, Mariarosaria Di Tommaso, Steven S. Witkin

Published in: Archives of Gynecology and Obstetrics | Issue 3/2019

Login to get access

Abstract

Purpose

Mechanisms leading to preterm premature rupture of membranes (PPROM) remain incompletely defined. Based on the elevated occurrence of PPROM in twin gestations and recent studies of the involvement of insulin-like growth factor binding protein-1 (IGFBP-1) in the inhibition of collagen production we hypothesized that serum IGFBP-1 levels might be predictive of susceptibility to PPROM in women with twins.

Methods

In this prospective study peripheral blood was obtained from 58 women with twin gestations prior to 20 weeks gestation and sera analyzed by ELISA for concentrations of IGFBP-1. Demographic and clinical outcome data were subsequently obtained and associations between IGFBP-1 and PPROM were analyzed by the Mann–Whitney test and receiver operator curve (ROC) analysis.

Results

Eight of our subjects developed PPROM. They did not differ from the other women in demographics, medical history or current pregnancy outcome parameters. However, median IGFBP-1 levels were higher in women who subsequently developed PPROM (59.3 ng/ml) than in the other women (46.6 ng/ml) (p = 0.042). Using a cutoff value of 53.9 ng/ml the circulating IGFBP-1 level predicted development of PPROM with a sensitivity of 74%, specificity of 75%, a negative predictive value of 97% and a positive predictive value of 20%.

Conclusions

Pending validation in larger studies the findings suggest that determination of serum IGFBP-1 levels in women with twin pregnancies may predict the later development of PPROM.
Literature
1.
go back to reference Mercer BM (2003) Preterm premature rupture of the membranes. Obstet Gynecol 101:178–193PubMed Mercer BM (2003) Preterm premature rupture of the membranes. Obstet Gynecol 101:178–193PubMed
2.
go back to reference Parry S, Strauss JF (1998) Premature rupture of the fetal membranes. N Eng J Med 338:663–670CrossRef Parry S, Strauss JF (1998) Premature rupture of the fetal membranes. N Eng J Med 338:663–670CrossRef
3.
go back to reference Menon R, Fortunato SJ, Yu J, Milne GL, Sanchez S, Drobek CO et al (2011) Cigarette smoke induces oxidative stress and apoptosis in normal term fetal membranes. Placenta 32:317–322CrossRefPubMed Menon R, Fortunato SJ, Yu J, Milne GL, Sanchez S, Drobek CO et al (2011) Cigarette smoke induces oxidative stress and apoptosis in normal term fetal membranes. Placenta 32:317–322CrossRefPubMed
4.
go back to reference Woods JR (2001) Reactive oxygen species and preterm premature rupture of membranes—a review. Placenta 22(Suppl A):S38–S44 Woods JR (2001) Reactive oxygen species and preterm premature rupture of membranes—a review. Placenta 22(Suppl A):S38–S44
5.
go back to reference Melamed N, Hadar E, Ben-Harhoush A, Kaplan B, Yogev Y (2009) Factors affecting the duration of the latency period in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 22:1051–1056CrossRefPubMed Melamed N, Hadar E, Ben-Harhoush A, Kaplan B, Yogev Y (2009) Factors affecting the duration of the latency period in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 22:1051–1056CrossRefPubMed
6.
go back to reference Kibel M, Barrett J, Tward C, Pittini A, Kahn M, Melamed N (2017) The natural history of preterm premature rupture of membranes in twin pregnancies. J Matern Neonatal Fetal Med 30(15):1829–1835CrossRef Kibel M, Barrett J, Tward C, Pittini A, Kahn M, Melamed N (2017) The natural history of preterm premature rupture of membranes in twin pregnancies. J Matern Neonatal Fetal Med 30(15):1829–1835CrossRef
7.
go back to reference Clemmons DR, Busby W, Clarke JB, Parker A, Duan C, Nam TJ (1998) Modification of insulin-like growth factor binding proteins and their role in controlling IGF actions. Endocrine J 45(Suppl):S1–S8CrossRef Clemmons DR, Busby W, Clarke JB, Parker A, Duan C, Nam TJ (1998) Modification of insulin-like growth factor binding proteins and their role in controlling IGF actions. Endocrine J 45(Suppl):S1–S8CrossRef
8.
go back to reference Novosyadlyy R, Lelbach A, Sheikh N, Tron K, Pannem R, Ramadori G et al (2009) Temporal and spacial expression of IGF-1 and IGFBP-1 during acute-phase response induced by local inflammation in rats. Growth Hormon IGF Res 19:51–60CrossRef Novosyadlyy R, Lelbach A, Sheikh N, Tron K, Pannem R, Ramadori G et al (2009) Temporal and spacial expression of IGF-1 and IGFBP-1 during acute-phase response induced by local inflammation in rats. Growth Hormon IGF Res 19:51–60CrossRef
9.
go back to reference Gillery P, Leperre A, Maquart FX, Borel JP (1992) Insulin-like growth factor-1 (IGF-1) stimulates protein synthesis and collagen gene expression in monolayer and lattice cultures of fibroblasts. J Cell Physiol 152:389–396CrossRefPubMed Gillery P, Leperre A, Maquart FX, Borel JP (1992) Insulin-like growth factor-1 (IGF-1) stimulates protein synthesis and collagen gene expression in monolayer and lattice cultures of fibroblasts. J Cell Physiol 152:389–396CrossRefPubMed
10.
go back to reference Prokop I, Kononczuk J, Surazynski A, Palka J (2013) Cross-talk between integrin receptor and insulin-like growth factor receptor in regulation of collagen biosynthesis in cultured fibroblasts. Adv Med Sci 58:292–297CrossRefPubMed Prokop I, Kononczuk J, Surazynski A, Palka J (2013) Cross-talk between integrin receptor and insulin-like growth factor receptor in regulation of collagen biosynthesis in cultured fibroblasts. Adv Med Sci 58:292–297CrossRefPubMed
11.
go back to reference Abbas A, Johnson M, Chard T, Nicolaides KH (1995) Maternal plasma concentrations of insulin-like growth factor binding protein-1 and placental protein 14 in multifetal pregnancies before and after fetal reduction. Hum Reprod. 10(1):207–210CrossRefPubMed Abbas A, Johnson M, Chard T, Nicolaides KH (1995) Maternal plasma concentrations of insulin-like growth factor binding protein-1 and placental protein 14 in multifetal pregnancies before and after fetal reduction. Hum Reprod. 10(1):207–210CrossRefPubMed
12.
go back to reference Committee on Practice Bulletins-Obstetrics (2018) ACOG practice bulletin no. 188: prelabor rupture of membranes. Obstet Gynecol 131(1):e1–e14CrossRef Committee on Practice Bulletins-Obstetrics (2018) ACOG practice bulletin no. 188: prelabor rupture of membranes. Obstet Gynecol 131(1):e1–e14CrossRef
13.
go back to reference Gupta MB, Abu Shehab M, Nygard K, Biggar K, Singal SS, Santoro N, Powell TL, Jansson T (2019) IUGR is associated with marked hyperphosphorylation of decidual and maternal plasma IGFBP-1. J Clin Endocrinol Metab 104(2):408–422CrossRefPubMed Gupta MB, Abu Shehab M, Nygard K, Biggar K, Singal SS, Santoro N, Powell TL, Jansson T (2019) IUGR is associated with marked hyperphosphorylation of decidual and maternal plasma IGFBP-1. J Clin Endocrinol Metab 104(2):408–422CrossRefPubMed
14.
go back to reference Wang HS, Lee JD, Cheng BJ, Soong YK (1996) Insulin-like growth factor-binding protein 1 and insulin-like growth factor-binding protein 3 in pre-eclampsia. Br J Obstet Gynaecol 103(7):654–659CrossRefPubMed Wang HS, Lee JD, Cheng BJ, Soong YK (1996) Insulin-like growth factor-binding protein 1 and insulin-like growth factor-binding protein 3 in pre-eclampsia. Br J Obstet Gynaecol 103(7):654–659CrossRefPubMed
15.
go back to reference Stone S, Langford K, Seed PT, Khamashta MA, Hunt BJ, Poston L (2003) Longitudinal analysis of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in antiphospholipid syndrome and in healthy pregnancy. Am J Obstet Gynecol. 189(1):274–279CrossRefPubMed Stone S, Langford K, Seed PT, Khamashta MA, Hunt BJ, Poston L (2003) Longitudinal analysis of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in antiphospholipid syndrome and in healthy pregnancy. Am J Obstet Gynecol. 189(1):274–279CrossRefPubMed
16.
go back to reference Fowler D, Albaiges G, Lees C, Jones J, Nicolaides K, Miell J (1999) The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by doppler ultrasound. Hum Reprod. 14(11):2881–2885CrossRefPubMed Fowler D, Albaiges G, Lees C, Jones J, Nicolaides K, Miell J (1999) The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by doppler ultrasound. Hum Reprod. 14(11):2881–2885CrossRefPubMed
17.
go back to reference Darj EG, Lyrenas S (1998) insulin-like growth factor binding protein-1, a quick way to detect amniotic fluid. Acta Obstet Gynecol Scand 77:295–297CrossRefPubMed Darj EG, Lyrenas S (1998) insulin-like growth factor binding protein-1, a quick way to detect amniotic fluid. Acta Obstet Gynecol Scand 77:295–297CrossRefPubMed
18.
go back to reference Chen CY, Chang CC, Lin CW (2015) Clinical application of immunomagnetic reduction for quantitative measurement of insulin-like growth factor binding protein-1 in the prediction of pregnant women with preterm premature rupture of membranes. Clin Chim Acta 438:337–341CrossRefPubMed Chen CY, Chang CC, Lin CW (2015) Clinical application of immunomagnetic reduction for quantitative measurement of insulin-like growth factor binding protein-1 in the prediction of pregnant women with preterm premature rupture of membranes. Clin Chim Acta 438:337–341CrossRefPubMed
19.
go back to reference Abdelazim IA (2014) Insulin-like growth factor binding protein-1 (Actim PROM test®) for detection of premature rupture of fetal membranes. J Obstet Gynecol Res. 40(4):961–967CrossRef Abdelazim IA (2014) Insulin-like growth factor binding protein-1 (Actim PROM test®) for detection of premature rupture of fetal membranes. J Obstet Gynecol Res. 40(4):961–967CrossRef
20.
go back to reference Abdelazim IA, Makhlouf HH (2013) Placental alpha microglobulin-1 (AmniSure test®) versus Insulin-like growth factor binding protein-1 (Actim PROM test) for detection of premature rupture of fetal membranes. J Obstet Gynecol Res. 39(6):1129–1136CrossRef Abdelazim IA, Makhlouf HH (2013) Placental alpha microglobulin-1 (AmniSure test®) versus Insulin-like growth factor binding protein-1 (Actim PROM test) for detection of premature rupture of fetal membranes. J Obstet Gynecol Res. 39(6):1129–1136CrossRef
21.
go back to reference Abdelazim IA, Al-Sherbeeny MM, Ibrahim ME, Fahmy AA, Rabei NH et al (2016) Insulin-like growth factor binding protein-1/ alpha-fetoprotein versus placental alpha microglobulin-1 for diagnosis of premature fetal membranes rupture. Acta Med Int 3(1):69–74CrossRef Abdelazim IA, Al-Sherbeeny MM, Ibrahim ME, Fahmy AA, Rabei NH et al (2016) Insulin-like growth factor binding protein-1/ alpha-fetoprotein versus placental alpha microglobulin-1 for diagnosis of premature fetal membranes rupture. Acta Med Int 3(1):69–74CrossRef
22.
go back to reference Abu-Faza M, Abdelazim IA, Svetlana S, Nusair B, Farag R et al (2018) Diagnostic accuracy of PremaQuick versus actim partus in prediction of preterm labor in symptomatic women within 14 days. Open J Obstet Gynecol 8(8):741–755CrossRef Abu-Faza M, Abdelazim IA, Svetlana S, Nusair B, Farag R et al (2018) Diagnostic accuracy of PremaQuick versus actim partus in prediction of preterm labor in symptomatic women within 14 days. Open J Obstet Gynecol 8(8):741–755CrossRef
Metadata
Title
Insulin-like growth factor binding protein-1 predicts preterm premature rupture of membranes in twin pregnancies
Authors
Giovanni Sisti
Sara Paccosi
Astrid Parenti
Viola Seravalli
Mariarosaria Di Tommaso
Steven S. Witkin
Publication date
01-09-2019
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 3/2019
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-019-05214-9

Other articles of this Issue 3/2019

Archives of Gynecology and Obstetrics 3/2019 Go to the issue

Gynecologic Endocrinology and Reproductive Medicine

Is muscle mechanical function altered in polycystic ovary syndrome?